Literature DB >> 18434945

Clinical validation of a real-time polymerase chain reaction detection of Neisseria gonorrheae porA pseudogene versus culture techniques.

Stig Ove Hjelmevoll1, Merethe Elise Olsen, Johanna U Ericson Sollid, Håkon Haaheim, Kjetil K Melby, Harald Moi, Magnus Unemo, Vegard Skogen.   

Abstract

BACKGROUND: Diagnosing Neisseria gonorrheae using nucleic acid amplification tests (NAATs) might increase the sensitivity, compared to cultivation. However, using NAATs has also been problematic mainly due to the close genetic relationships between different Neisseria species, resulting in false positive diagnoses. This study was conducted to clinically validate a previously published real-time polymerase chain reaction (PCR) method targeting the porA pseudogene in N. gonorrheae in comparison to culture techniques.
METHODS: In total, 360 samples, urethra (n = 109), rectum (n = 84), pharynx (n = 119), and cervix (n = 48) from 185 males and 57 females, were analyzed using porA pseudogene PCR and cultivation. Sequencing of the entire porA pseudogene and the 16S rRNA gene were used to resolve discrepant results.
RESULTS: Of the 360 samples, 37 were positive by both culture and PCR, however, the PCR identified 15 additional confirmed positive samples. The PCR method showed a sensitivity, specificity, positive predictive value, and negative predictive value of 100% in a preselected population. The preselected population had a true gonorrhea prevalence of 17.4%.
CONCLUSIONS: The present porA pseudogene real-time PCR comprises a valuable supplement to the traditional culture techniques for diagnosis of N. gonorrheae, especially for samples from extragenital sites such as pharynx and rectum.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18434945     DOI: 10.1097/OLQ.0b013e3181644bc9

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  6 in total

1.  Successful Combination of Nucleic Acid Amplification Test Diagnostics and Targeted Deferred Neisseria gonorrhoeae Culture.

Authors:  Carolien M Wind; Henry J C de Vries; Maarten F Schim van der Loeff; Magnus Unemo; Alje P van Dam
Journal:  J Clin Microbiol       Date:  2015-04-01       Impact factor: 5.948

2.  Neisseria gonorrhoeae strain with high-level resistance to spectinomycin due to a novel resistance mechanism (mutated ribosomal protein S5) verified in Norway.

Authors:  Magnus Unemo; Daniel Golparian; Vegard Skogen; Anne Olaug Olsen; Harald Moi; Gaute Syversen; Stig Ove Hjelmevoll
Journal:  Antimicrob Agents Chemother       Date:  2012-11-26       Impact factor: 5.191

3.  Molecular detection and confirmation of Neisseria gonorrhoeae in urogenital and extragenital specimens using the Abbott CT/NG RealTime assay and an in-house assay targeting the porA pseudogene.

Authors:  A Walsh; F O Rourke; B Crowley
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-12-19       Impact factor: 3.267

4.  Phenotypic and genotypic properties of Neisseria gonorrhoeae isolates in Norway in 2009: antimicrobial resistance warrants an immediate change in national management guidelines.

Authors:  S O Hjelmevoll; D Golparian; L Dedi; D H Skutlaberg; E Haarr; A Christensen; S Jørgensen; Ø J Nilsen; M Unemo; V Skogen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-09-30       Impact factor: 3.267

5.  Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in an STI population: performances of the Presto CT-NG assay, the Lightmix Kit 480 HT CT/NG and the COBAS Amplicor with urine specimens and urethral/cervicovaginal samples.

Authors:  T A Schuurs; S P Verweij; J F L Weel; S Ouburg; S A Morré
Journal:  BMJ Open       Date:  2013-12-30       Impact factor: 2.692

6.  Conventional Agar-Based Culture Method, and Nucleic Acid Amplification Test (NAAT) of the cppB Gene for Detection of Neisseria gonorrhea in Pregnant Women Endocervical Swab Specimens.

Authors:  Parvin Hassanzadeh; Jalal Mardaneh; Mohammad Motamedifar
Journal:  Iran Red Crescent Med J       Date:  2013-03-05       Impact factor: 0.611

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.